Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 20.60
-0.60 (-2.83%)
Aug 1, 2025, 5:17 PM CET
STO:MAGLE Revenue
Magle Chemoswed Holding AB had revenue of 55.24M SEK in the quarter ending June 30, 2025, with 19.43% growth. This brings the company's revenue in the last twelve months to 290.43M, up 57.25% year-over-year. In the year 2024, Magle Chemoswed Holding AB had annual revenue of 240.57M with 40.27% growth.
Revenue (ttm)
290.43M
Revenue Growth
+57.25%
P/S Ratio
1.46
Revenue / Employee
2.00M
Employees
147
Market Cap
422.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 240.57M | 69.07M | 40.27% |
| Dec 31, 2023 | 171.50M | 23.51M | 15.89% |
| Dec 31, 2022 | 147.98M | 15.84M | 11.98% |
| Dec 31, 2021 | 132.15M | -10.19M | -7.16% |
| Dec 31, 2020 | 142.34M | 10.55M | 8.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.31B |
| Getinge AB | 35.50B |
| Camurus AB | 2.27B |
| Medicover AB | 25.22B |
| Asker Healthcare Group AB | 15.88B |
| Bonesupport Holding AB | 1.06B |
| AddLife AB | 10.44B |